Nisa Investment Advisors, LLC Merck & Co., Inc. Transaction History

Nisa Investment Advisors, LLC

$15.2 Billion
Q1 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 707,835 shares of MRK stock, worth $87.6 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

707,835

Previous 719,479 1.62%

Holding current value

$87.6 Million

Previous $78.4 Million 19.07%

% of portfolio

0.62%

Previous 0.56%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$113.24 - $131.95 $1.32 Million - $1.54 Million	-11,644 Reduced 1.62%	707,835 $93.4 Million
Q4 2023 Jan 25, 2024	SELL	$100.18 - $109.02 $3.06 Million - $3.33 Million	-30,511 Reduced 4.07%	719,479 $78.4 Million
Q3 2023 Nov 02, 2023	SELL	$102.95 - $114.33 $811,863 - $901,606	-7,886 Reduced 1.04%	749,990 $77.2 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $1.77 Million - $1.93 Million	-16,270 Reduced 2.1%	757,876 $87.5 Million
Q1 2023 May 02, 2023	BUY	$102.94 - $114.86 $793,770 - $885,685	7,711 Added 1.01%	774,146 $82.4 Million

Q4 2022 Feb 02, 2023	SELL	$87.44 - $112.11 $60,595 - $77,692	-693 Reduced 0.09%	766,435 $85 Million
Q3 2022 Nov 07, 2022	SELL	$84.53 - $94.96 $972,433 - $1.09 Million	-11,504 Reduced 1.48%	767,128 $66.2 Million
Q2 2022 Aug 03, 2022	SELL	$83.49 - $94.64 $559,967 - $634,750	-6,707 Reduced 0.85%	778,632 $71 Million
Q1 2022 Apr 29, 2022	SELL	$73.51 - $82.4 $416,875 - $467,290	-5,671 Reduced 0.72%	785,339 $64.4 Million
Q4 2021 Feb 03, 2022	SELL	$72.28 - $90.54 $963,781 - $1.21 Million	-13,334 Reduced 1.66%	791,010 $64.5 Million
Q3 2021 Oct 18, 2021	SELL	$71.68 - $78.83 $2.64 Million - $2.9 Million	-36,793 Reduced 4.37%	804,344 $60.4 Million
Q2 2021 Aug 06, 2021	SELL	$70.31 - $77.77 $3.5 Million - $3.87 Million	-49,767 Reduced 5.59%	841,137 $65.4 Million
Q1 2021 Apr 26, 2021	SELL	$68.86 - $81.11 $7.11 Million - $8.37 Million	-103,184 Reduced 10.38%	890,904 $68.7 Million
Q4 2020 Jan 25, 2021	SELL	$71.77 - $79.65 $11,124 - $12,345	-155 Reduced 0.02%	994,088 $81.3 Million
Q3 2020 Oct 20, 2020	SELL	$73.18 - $82.95 $461,473 - $523,082	-6,306 Reduced 0.63%	994,243 $82.5 Million
Q2 2020 Jul 27, 2020	SELL	$70.42 - $80.13 $2.53 Million - $2.88 Million	-35,985 Reduced 3.47%	1,000,549 $77.4 Million
Q1 2020 Apr 17, 2020	SELL	$63.36 - $87.82 $2.17 Million - $3 Million	-34,202 Reduced 3.19%	1,036,534 $79.8 Million
Q4 2019 Jan 17, 2020	SELL	$77.58 - $87.54 $364,005 - $410,737	-4,692 Reduced 0.44%	1,070,736 $97.4 Million
Q3 2019 Oct 17, 2019	SELL	$76.08 - $82.93 $999,691 - $1.09 Million	-13,140 Reduced 1.21%	1,075,428 $90.5 Million
Q2 2019 Jul 12, 2019	SELL	$69.84 - $81.59 $3.24 Million - $3.79 Million	-46,456 Reduced 4.09%	1,088,568 $91.3 Million
Q1 2019 Apr 17, 2019	SELL	$69.58 - $79.36 $34,163 - $38,965	-491 Reduced 0.04%	1,135,024 $94.4 Million
Q4 2018 Jan 17, 2019	BUY	$65.24 - $75.71 $1.5 Million - $1.74 Million	23,019 Added 2.07%	1,135,515 $86.8 Million
Q3 2018 Oct 16, 2018	BUY	$57.69 - $67.84 $580,361 - $682,470	10,060 Added 0.91%	1,112,496 $78.9 Million
Q2 2018 Jul 19, 2018	BUY	$50.83 - $59.72 $2.27 Million - $2.67 Million	44,720 Added 4.23%	1,102,436 $66.9 Million
Q1 2018 Apr 10, 2018	SELL	$50.96 - $59.23 $1.99 Million - $2.31 Million	-39,080 Reduced 3.56%	1,057,716 $57.6 Million
Q4 2017 Jan 12, 2018	SELL	$51.62 - $61.64 $1.3 Million - $1.55 Million	-25,178 Reduced 2.24%	1,096,796 $61.7 Million
Q3 2017 Oct 13, 2017	BUY	$58.67 - $63.13 $65.8 Million - $70.8 Million	1,121,974	1,121,974 $71.8 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Merck & Co., Inc. Transaction History